Japan is considering a new approach to its “special” market expansion re-pricing that would exclude drug sales tied to private…
HOME > BUSINESS
BUSINESS
- Novartis Corrects Third-Party Investigation Report on Diovan Studies
August 12, 2013
- DSP to Set Up Regenerative & Cellular Medicine Office for Integrated Management of All Related Functions
August 12, 2013
- AZ’s Exenatide Promotion to Break Free from Weight-Loss Image of GLP-1 Receptor Agonists
August 9, 2013
- Ethical Drug Sales Down 0.1% in June: Crecon Report
August 9, 2013
- Seikagaku Obtains Favorable Results from PIII Study of Condoliase for Lumbar Disc Herniation, Plans to File NDA in Japan During FY2013
August 9, 2013
- Meiji Seika Pharma Changes New Drug Plan in the CNS Field; Filing and Launch of Asenapine to Take Priority
August 9, 2013
- Sawai Lifts Limit Restrictions on Atelec Generic Supplies
August 8, 2013
- DSP Aims for Better Communications with Wholesalers, Regulators with Tokyo-Osaka Two Head Office System
August 8, 2013
- Top 4 Wholesalers Report Average Price Agreement Rate of 63.4% at End of June, Down 7.5 Points from 2 Years Prior
August 8, 2013
- Takeda to Merge Bio Development Center following Acquisition of Its Operations
August 7, 2013
- Eli Lilly Paid 16.3 Billion Yen in 2012 to Doctors, Medical Institutions
August 7, 2013
- Janssen, Mochida to Comarket Pain Treatment Tramcet Combination Tablets from October
August 6, 2013
- Toyama Chemical Starts Commercial Production at Newly-Established Plant for Injectables
August 6, 2013
- Eisai Sales Up 5.0%, Helped by Growth of New Products
August 5, 2013
- Sales of Eisai’s Obesity Treatment Belviq Exceeds US$10 Million Three Weeks after Launch
August 5, 2013
- Astellas’s First-Quarter Net Profit Down 27% Despite Increases in Sales; 5% Decline in Domestic Sales Due to Impact of Generics
August 5, 2013
- MTPC to Consolidate Domestic Manufacturing Plants, Transferring Ashikaga Plant to CMIC Holdings
August 5, 2013
- Apo Plus to Hire 1,000 Contract MRs by 2013-End
August 2, 2013
- Daiichi Sankyo to Cut 400 to 500 Workers in Europe
August 2, 2013
- Daiichi Sankyo Sales Up 4% in First Quarter, Profits Down due to Ranbaxy Business Slump
August 2, 2013
ページ
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
As Japan approaches the Fiscal System Council’s “autumn recommendation,” a notable shift is taking shape. The Ministry of Finance (MOF),…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…